Oetgen Stephen Duane
SEC CIK 2126570 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARXS | Arxis, Inc. | Dir | 5,357 | $700.0K | — | 2 | 2026-04-17 | 2026-04-17 |
Most active insiders at ARXS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Roth Jason Aaron | See Remarks | $1.68M | — |
| 2 | Perhamus Kevin Scott | See Remarks, Dir | $1.50M | — |
| 3 | Badakhsh Azad Sid | See Remarks | $1.01M | — |
| 4 | Oetgen Stephen Duane | Dir | $700.0K | — |
| 5 | Sealfon Ross Bradley | See Remarks | $350.0K | — |
| 6 | ALLEN PATRICK E | Dir | $280.0K | — |
| 7 | Jankowski Ryan Anthony | CAO | $125.0K | — |
| 8 | Arcline Double Eagle Master Fund-A LP | Dir, 10% | — | — |
| 9 | Allen Jennifer H. | See Remarks | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-20 21:07 | 2026-04-17 | ARXS | Arxis, Inc. | Oetgen Stephen Duane | Dir | A - Grant | $0.00 | +5,357 | 5,357 | New | $0 | |
| 2026-04-20 21:07 | 2026-04-17 | ARXS | Arxis, Inc. | Oetgen Stephen Duane | Dir | P - Purchase | $28.00 | +25.0K | 30.4K | +467% | +$700.0K |
Purchase Sale Sale after option exercise All abbreviations